Biosensor for direct determination of fenitrothion and EPN using recombinant <Emphasis Type="Italic">Pseudomonas putida</Emphasis> JS444 with surface-expressed organophosphorous hydrolase. 2. Modified carbon paste electrode

A whole cell-based amperometric biosensor for highly selective, sensitive, rapid, and cost-effective determination of the organophosphate pesticides fenitrothion and ethyl p-nitrophenol thiobenzenephosphonate (EPN) is discussed. The biosensor comprised genetically engineered p-nitrophenol (PNP)-degrading bacteria Pseudomonas putida JS444 anchoring and displaying organophosphorous hydrolase (OPH) on its cell surface as biological sensing element and carbon paste electrode as the amperometric transducer. Surface-expressed OPH catalyzed the hydrolysis of organophosphorous pesticides such as fenitrothion and EPN to release PNP and 3-methyl-4-nitrophenol, respectively, which were subsequently degraded by the enzymatic machinery of P. putida JS444 through electrochemically active intermediates to the TCA cycle. The electrooxidization current of the intermediates was measured and correlated to the concentration of organophosphates. Operating at optimum conditions, 0.086 mg dry wt of cell operating at 600 mV of applied potential (vs Ag/AgCl reference) in 50 mM citratephosphate buffer, pH 7.5, with 50 μM CoCl₂ at room temperature, the biosensor measured as low as 1.4 ppb of fenitrothion and 1.6 ppb of EPN. There was no interference from phenolic compounds, carbamate pesticides, triazine herbicides, or organophosphate pesticides without nitrophenyl substituent. The service life of the biosensor and the applicability to lake water were also demonstrated.     

Singlet diradical complexes of chromium, molybdenum, and tungsten with azo anion radical ligands from M(CO)6 precursors

The homoleptic diamagnetic complexes M(mer-L)(2), M = Cr, Mo,W (1a,b, 2a,b, and 4a,b), were obtained by reacting the hexacarbonyls M(CO)(6) with the tridentate ligands 2-[(2-N-arylamino)phenylazo]pyridine (HL = NH(4)C(5)N=NC(6)H(4)N(H)C(6)H(4)(H) (HL(a)) or NH(4)C(5)N=NC(6)H(4)N(H)C(6)H(4)(CH(3)) (HL(b))) in refluxing n-octane. In the case of M = Mo, the dinuclear compounds [Mo(L)(pap)](2)(mu-O) (3a,b) (pap = 2-(phenylazo)pyridine), were obtained as second products in moist solvent. X-ray diffraction analysis for Cr(L(b))(2) (1b), Mo(L(a))(2) (2a), and W(L(a))(2) (4a) reveals considerably distorted-octahedral structures with trans-positioned azo-N atoms and cis-positioned 2-pyridyl-N and anilido nitrogen atoms. Whereas the N(azo)-M-N(azo) angle is larger than 170 degrees, the other two trans angles are smaller, at about 155 degrees (M = Cr, 1b) or 146 degrees (M = Mo, W; 2a, 4a), due to the overarching bite of the mer-tridentate ligands. The bonds from M to the neutral 2-pyridyl-N atoms are distinctly longer by more than 0.08 A than those to the anilido or azo nitrogen atoms, reflecting negative charge on the latter. The N-N bond distances vary between 1.339(2) A for 1b and 1.373(3) A for 4a, clearly indicating the azo radical anion oxidation state. Considering the additional negative charge on anilido-N, the mononuclear complexes are thus formulated as M(IV)(L*(2-))(2). The diamagnetism of the complexes as shown by magnetic susceptibility and (1)H NMR experiments is believed to result from spin-spin coupling between the trans-positioned azo radical functions, resulting in a singlet diradical situation. The experimental structures are well reproduced by density functional theory calculations, which also support the overall electronic structure indicated. The dinuclear 3a with N-N distances of 1.348(10) A for L(a) and 1.340(9) A for pap is also formulated as an azo anion radical-containing molybdenum(IV) species, i.e., [Mo(IV)(L*(2-))(pap*-)](2)(mu-O). All compounds can be reversibly reduced; the Cr complexes 1a,b are also reversibly oxidized in two steps. Electron paramagnetic resonance spectroscopy indicates metal-centered spin for 1a+ and 1a- and g approximately 2 signals for 2a-, 3a+, 3a-, and 4a-. Spectroelectrochemistry in the UV-vis-NIR region showed small changes for the reduction of 2a, 3a, and 4a but extensive spectral changes for the reduction and oxidation of 1a.     

Simple and efficient synthesis of thysanone methyl ether

The synthesis of thysanone methyl ether is achieved by employing semivioxanthin methyl ether, which in turn is prepared by the tandem Michael addition of an anion of orsellinate to a substituted dihydropyrone.     

An Unusual Synthesis of Arylazo Substituted Azaphospha [5, 1-A] Quinolines by Reaction of N-Alkylarylazo Quinolinium Salts with Phosphorus Trichloride

1,2-Dialkyl-3-arylazo quinolinium chloride 1 having N-methylene group activated by the insertion of arylazo site react with phosphorus trichloride to give N-(dichloro phosphinomethylene) quinolinium ylide 2 . The site of the reaction is determined by the relative activation of 1- and 2-methylene groups, in the absence of sufficient activation of N-methylene group, reactions occur at the 2-methylene group to give dichloro phosphinylated anhydrobases 5 and 11.     

Spectrophotometric determination of phenylhydrazine with ammonium molybdate

Summary The determination of phenyl hydrazine is done by reaction with ammonium molybdate; the pink colour procedud is extracted inton-butanol. 100–1300g of phenyl hydrazine can be determined at 510 nm. The effect of time, temperature, ammonium molybdate concentration and interferences has been studied.

---

Zusammenfassung Die Bestimmung von Phenylhydrazin erfolgt auf der Grundlage seiner Reaktion mit Ammoniummolybdat. Die rosa Färbung wird mitn-Butanol extrahiert. 0,1–1,3 mg Phenylhydrazin können bei 510 nm gemessen werden. Der Einfluß der Reaktionszeit, der Temperatur, der Reagenskonzentration sowie auftretende Störungen wurden untersucht.

     

Singlet diradical complexes of ruthenium and osmium: geometrical and electronic structures and their unexpected changes on oxidation

Reaction of HL, HLa (2-[(2-N-phenylamino)phenylazo]pyridine), HLb (2-[{2-N-(4-methylphenyl)amino}phenylazo]pyridine), or HLc (2-[{2-N-(4-chlorophenyl)amino}phenylazo]pyridine), with KRuO4 or OsO4 and PPh3 under exhaustive deoxygenation (PPh3 --> OPPh3) yields diamagnetic compounds ML2. Crystal structure determination for M(La)2 indicates the radical dianion state, L2(.-), for the ligands as evident from the typical N-N bond length of about 1.33 A for a one-electron reduced azo function. The resulting spin-coupled complexes, MIV(L(2.-))2, can be oxidized in two reversible one-electron steps, as probed by cyclic voltammetry and UV-vis-NIR spectroelectrochemistry. The paramagnetic intermediates, [M(La)2]+, are distinguished by intense NIR absorption, largely metal-centered spin as revealed by EPR, and, in the case of [Os(La)2]I3, by crystallographically determined shortening of the NN bond to about 1.30 A, corresponding to a coordinated unreduced azo function. Thus, oxidation of the complex MIV(L(2.-))2 involves partial reduction of the metal in [MIII(L-)2]+ because intramolecular double electron transfer is offsetting the external charge removal. Density-functional theory calculations were employed to confirm the structural features and to support the spectroscopic assignments.     

Pseudo-base formation in the attempted synthesis of a conjugatively coupled bis(nitrosylruthenium) complex and spectroelectrochemistry of bipyrimidine-bridged dinuclear Ru(terpy)X precursor compounds (X = Cl, NO2)

Reaction of {(mu-bpym)[RuCl(terpy)]2}(PF6)2, bpym = 2,2'-bipyrimidine and terpy = 2,2':6',2'-terpyridine, with NaNO2 yields {(mu-bpym)[Ru(NO2)(terpy)]2}(PF6)2. In CH3CN/0.1 M Bu4NPF6 both dinuclear complexes can undergo two reversible bpym-centered one-electron reduction processes and two metal-centered one-electron oxidation steps, the latter involving mixed-valent intermediates with weak intermetallic coupling. Acidification of {(mu-bpym)[Ru(NO2)(terpy)]2}(PF6)2 does not lead to the expected {(mu-bpym)[Ru(NO)(terpy)]2}6+ but, probably because of the high charge, to the insoluble but structurally and IR-spectroscopically characterised pseudo-base product syn-{(mu-bpym-(4-OH))[Ru(NO)(terpy)]2}(PF6)5. The addition of one hydroxide to one of the 4-positions of bis-chelating bpym interrupts the aromatic pi conjugation and is accompanied by corresponding intra-pyrimidine bond length variations, however, the effect on the electronic interaction of the two different syn positioned {RuNO}6 moieties remains small, possibly due to their situation within the central molecular pi plane.     

Targeted disruption of the CCR5 gene in human hematopoietic stem cells stimulated by peptide nucleic acids

Peptide nucleic acids (PNAs) bind duplex DNA in a sequence-specific manner, creating triplex structures that can provoke DNA repair and produce genome modification. CCR5 encodes a chemokine receptor required for HIV-1 entry into human cells, and individuals carrying mutations in this gene are resistant to HIV-1 infection. Transfection of human cells with PNAs targeted to the CCR5 gene, plus donor DNAs designed to introduce stop codons mimicking the naturally occurring CCR5-delta32 mutation, produced 2.46% targeted gene modification. CCR5 modification was confirmed at the DNA, RNA, and protein levels and was shown to confer resistance to infection with HIV-1. Targeting of CCR5 was achieved in human CD34(+) hematopoietic stem cells (HSCs) with subsequent engraftment into mice and persistence of the gene modification more than four months posttransplantation. This work suggests a therapeutic strategy for CCR5 knockout in HSCs from HIV-1-infected individuals, rendering cells resistant to HIV-1 and preserving immune system function.     

Protective role of estrogen against excessive erythrocytosis in Monge’s disease

Monge’s disease (chronic mountain sickness (CMS)) is a maladaptive condition caused by chronic (years) exposure to high-altitude hypoxia. One of the defining features of CMS is excessive erythrocytosis with extremely high hematocrit levels. In the Andean population, CMS prevalence is vastly different between males and females, being rare in females. Furthermore, there is a sharp increase in CMS incidence in females after menopause. In this study, we assessed the role of sex hormones (testosterone, progesterone, and estrogen) in CMS and non-CMS cells using a well-characterized in vitro erythroid platform. While we found that there was a mild (nonsignificant) increase in RBC production with testosterone, we observed that estrogen, in physiologic concentrations, reduced sharply CD235a⁺ cells (glycophorin A; a marker of RBC), from 56% in the untreated CMS cells to 10% in the treated CMS cells, in a stage-specific and dose-responsive manner. At the molecular level, we determined that estrogen has a direct effect on GATA1, remarkably decreasing the messenger RNA (mRNA) and protein levels of GATA1 (p < 0.01) and its target genes (Alas2, BclxL, and Epor, p < 0.001). These changes result in a significant increase in apoptosis of erythroid cells. We also demonstrate that estrogen regulates erythropoiesis in CMS patients through estrogen beta signaling and that its inhibition can diminish the effects of estrogen by significantly increasing HIF1, VEGF, and GATA1 mRNA levels. Taken altogether, our results indicate that estrogen has a major impact on the regulation of erythropoiesis, particularly under chronic hypoxic conditions, and has the potential to treat blood diseases, such as high altitude severe erythrocytosis.Subject terms: Haematopoietic stem cells, Myeloproliferative disease